Hormel Foods Corporation enters its May 28 Q2 earnings window down roughly 10% over the past month, trading at $20.86 — a level that puts the P/E ratio at just under 14x and drags the EV/EBITDA multiple to approximately 10x. Both multiples have compressed steadily across the past 30 days as the stock has failed to find a floor.
The most consequential shift this week came from the Street. JP Morgan's Thomas Palmer downgraded HRL to Neutral from Overweight on April 9, cutting his target from $28 to $23 — the clearest vote of no-confidence from a major house in recent months. That leaves the stock more than 10% below its new JP Morgan target, and well below the consensus mean of $26.75. The broader analyst picture is mixed but leaning cautious: targets have drifted lower across multiple revisions over the past six months, and the gap between the current price and consensus implies roughly 25% upside — a spread wide enough to reflect genuine uncertainty rather than residual optimism. The analyst recommendation divergence score ranks in just the 11th percentile, suggesting the Street is more unified in its caution than the surface-level average might imply.
Short positioning tells a less dramatic story than the price action suggests. Short interest as a percentage of free float is running at 4.1%, up about 9.5% over the past month but having pulled back nearly 5% in the most recent week. The intra-month spike — short interest briefly touched highs near 26.2 million shares around April 13 — has partly unwound. Borrowing costs remain negligible at 0.45%, and the borrow market is far from tight: availability remains ample, with the lending pool operating well within normal range and the 52-week utilization peak of 26.3% (hit on April 13) already receding. The ORTEX short score of 43.4 has been drifting lower all week, signalling that the short-side pressure is easing rather than building. Days-to-cover at around five days is elevated but not alarming.
Options traders are not adding meaningful directional weight to the bearish case. The put/call ratio at 0.41 is slightly below its 20-day average of 0.42, with a z-score of -0.46 — close to neutral. The 52-week PCR range runs from 0.34 to 0.62, and the current reading is in the lower half of that band, indicating that options flow has actually tilted modestly toward calls relative to recent history. That contrasts with the share-price weakness and the JP Morgan downgrade, and suggests options traders are not aggressively hedging into the Q2 print.
The ownership structure is worth noting for context. The Hormel Foundation controls 46.6% of shares and has not moved. Vanguard, State Street and BlackRock are all sitting close to their recent allocations, with only small adjustments in the most recent quarter. Dimensional Fund Advisors added roughly 1.6 million shares through March, and Citadel put on around 2.5 million — both meaningful increments for a stock this size, suggesting some systematic or quant interest at current levels. The dividend score ranks in the 98th percentile, with a forward yield near 5.5% — a figure that has become more prominent as the share price has fallen.
Among close peers, MDLZ stood out this week, gaining 4.3% on the day and nearly 9% on the week — a notable divergence from HRL's 2.7% weekly decline. CAG and GIS both lost around 2% on the week, making HRL's performance broadly in line with the weaker corner of the packaged foods group rather than an outlier.
The next hard date is May 28, when HRL reports Q2 2026. The February print produced a modest one-day gain of 1.1% before fading to a five-day loss of 4.4% — a pattern of relief followed by reassessment that the market will be watching for again. With the stock now trading at a multi-year discount and JP Morgan having freshly reset its anchor, the Q2 revenue trend and any update on volume recovery in the foodservice segment will define whether the current valuation compression represents a floor or a way-station.
See the live data behind this article on ORTEX.
Open HRL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
